Cancer Research Coordinating Committee (CRCC) Funded Publications
Parent: University of California Research Initiatives
eScholarship stats: Breakdown by Item for September through December, 2024
Item | Title | Total requests | Download | View-only | %Dnld |
---|---|---|---|---|---|
8ck6g0xp | A DNA aptamer for binding and inhibition of DNA methyltransferase 1. | 26 | 3 | 23 | 11.5% |
0ww2h0j5 | Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells | 25 | 1 | 24 | 4.0% |
9wq0h1n3 | Adenosine A2a receptors form distinct oligomers in protein detergent complexes | 24 | 7 | 17 | 29.2% |
17z5v0x6 | Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer | 22 | 1 | 21 | 4.5% |
9qw9t9zc | Structure and function of G protein-coupled receptor oligomers: implications for drug discovery | 21 | 9 | 12 | 42.9% |
3012r2z7 | Copy number networks to guide combinatorial therapy of cancer and proliferative disorders | 20 | 5 | 15 | 25.0% |
3c03q2r2 | Rapid Enrichment and Detection of Extracellular Vesicles Enabled by CuS-Enclosed Microgels. | 20 | 1 | 19 | 5.0% |
46n9603r | Scalable Total Synthesis, IP3R Inhibitory Activity ofDesmethylxestospongin B, and Effect on Mitochondrial Function andCancer Cell Survival | 19 | 5 | 14 | 26.3% |
6476b5js | Automatic Small RNA Extraction and Processing by a Multichannel/Multiwell Chip | 18 | 2 | 16 | 11.1% |
65m374m7 | Oil-in-Water-in-Oil Multinanoemulsions for Templating Complex Nanoparticles | 18 | 11 | 7 | 61.1% |
0d34348t | Metabolite Responsive Nanoparticle-Protein Complex | 14 | 3 | 11 | 21.4% |
17k970vv | Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity And Induces Tumor Cell Death. | 14 | 2 | 12 | 14.3% |
4wn320f9 | Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition. | 13 | 2 | 11 | 15.4% |
7f71c92q | Investigations into Wnt modulation of p27(KIP1) turnover and the E3 ligase substrate adaptor DDB1 and CUL4 Associated Factor 4 | 13 | 0 | 13 | 0.0% |
6s658298 | Pre-clinical development of gene modification of hematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy | 10 | 0 | 10 | 0.0% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.